Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial

Faster, Cleaner, Better.

Impact Biomedical Inc (IBO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Cash Flow for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	06-2023	03-2023	12-2022	09-2022	06-2022
Cash Flows From Operating Activities
Net Income	-1,969	-849	-7,255	-3,889	-1,545
Depreciation Amortization	560	280	1,113	835	556
Income taxes - deferred	N/A	N/A	N/A	1,258	N/A
Accounts receivable	-94	N/A	N/A	N/A	-37
Accounts payable and accrued liabilities	-238	-353	N/A	-71	-6
Other Working Capital	-338	-445	421	-83	-88
Other Operating Activity	332	353	3,479	71	43
Operating Cash Flow	$-1,747	$-1,014	$-2,242	$-1,879	$-1,077

Cash Flows From Investing Activities
PPE Investments	-17	-5	-276	N/A	N/A
Purchase Of Investment	N/A	N/A	N/A	-65	-65
Other Investing Activity	2	1	-73	-9	-8
Investing Cash Flow	$-15	$-4	$-349	$-74	$-73

Cash Flows From Financing Activities
Change In Short Term Borrowing	1,763	1,017	N/A	2,008	1,235
Other Financing Activity	0	0	2,547	0	0
Financing Cash Flow	$1,763	$1,017	$2,547	$2,008	$1,235

Beginning Cash Position	2	2	46	46	46
End Cash Position	3	1	2	101	131
Net Cash Flow	$1	$-1	$-44	$55	$85

Free Cash Flow
Operating Cash Flow	-1,747	-1,014	-2,242	-1,879	-1,077
Capital Expenditure	-17	-5	N/A	N/A	N/A
Free Cash Flow	-1,764	-1,019	-2,242	-1,879	-1,077